NGDI Ebola Symposium for Treatment and Action
On November 13, 2014 UBC’s Neglected Global Diseases Initiative at UBC (NGDI-UBC) in partnership with the Vancouver Coastal Health Research Institute and The Centre for Drug Research and Development (CDRD), Canada’s national not-for-profit drug development and commercialization centre, brought together leading researchers from across the country to discuss Ebola Treatment and Action. The meeting focused on Canada’s current contributions to potential therapeutics in response to the 2014 West African outbreak of Ebola Virus Disease (EVD) and the opinions of Canadian Public Health officials and researchers for the prevention, and control of infection domestically.
NEW Please access the event recording here.
NEW For printing, the recorded program timing and speaker biographies is here.
If by chance the above link is not working please copy the following into your url: http://mediasitemob1.mediagroup.ubc.ca/Mediasite/Play/
New items for symposium:
Vancouver Sun, Nov 12, 2014: New B.C. network to coordinate local response to Ebola crisis
The Plight of Ebola: Canadian Researchers Come Together to Combat the Outbreak
Time: 1:00—5:30 PM reception to follow
Location: London Drugs Theatre, Pharmaceutical Sciences, 2045 Wesbrook Mall @ Agronomy Road
There are presently three Canadian contributions to potential therapeutics and vaccines for the Ebola Virus Disease that are being fast-tracked through clinical trials. Two of these are TKM-Ebola and ZMapp. Our two keynote speakers will discuss the science behind these interventions. Our expert panel members will present and discuss on a wide-range of topics about Ebola: public health, methods of fast-tracking clinical trials, infection control and working in the field.
Overview of 2014 Ebola Outbreak and BC and Canada’s readiness:
Bonnie Henry, MD MPH Deputy Provincial Health Officer, British Columbia Ministry of Health; Associate Professor, School of Population and Public Health, Faculty of Medicine, UBC
Keynote Presentations of Canada’s contributions:
Dr. Ian MacLachlan Executive Vice President and Chief Technical Officer, Tekmira Pharmaceuticals Corporation
Dr. Xiangguo Qiu Head of Serology Diagnostics Unit in Special Pathogens, National Microbiology Laboratories, Public Health Agency of Canada
Expert Panel Presentations
Christopher Lowe, MSc MD FRCPC, Medical Microbiologist, Infection and Control Physician, Providence Health Care
Steve Kanters, PhD(c) MSc Research Associate, Centre for Clinical Epidemiology and Evaluation; and Research Manager and Statistician, Global Evaluative Sciences
Jan Hajek, MD FRCPC Clinical Assistant Professor, Division Infectious Diseases, Department of Medicine, Faculty of Medicine, UBC
Stephanie Parent, MPH(c) WHO Collaborating Centre for Occupational and Environmental Health, School of Population and Public Health, Faculty of Medicine
Srinivas Murthy, MD Division of Critical Care, BC Children’s Hospital; World Health Organization National Lead – Liberia; Case Management Ebola Response.
Expert Panel Question and Answer Period